PTCT - PTC THERAPEUTICS, INC.
64.29
-0.100 -0.156%
Share volume: 1,230,000
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$64.39
-0.10
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-25-2024 | 08-08-2024 | 11-07-2024 | 02-27-2025 | 05-06-2025 | 08-07-2025 | 11-04-2025 | 02-19-2026 | |
| Assets | |||||||||
| Total Assets | 1.790 B | 1.916 B | 1.842 B | 1.705 B | 2.655 B | 2.634 B | 2.644 B | 2.899 B | |
| Current Assets | 1.169 B | 1.358 B | 1.282 B | 1.366 B | 2.316 B | 2.273 B | 2.008 B | 2.274 B | |
| Inventories | 30.058 M | 31.826 M | 35.671 M | 23.194 M | 21.675 M | 34.061 M | 52.688 M | 79.647 M | |
| Other Current Assets | 56.207 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 56.207 M | 438.514 M | 487.356 M | 359.987 M | 546.950 M | 971.764 M | 1.015 B | 960.723 M | |
| Total Receivables | 197.660 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 884.813 M | 654.779 M | 526.001 M | 779.709 M | 1.480 B | 1.017 B | 672.617 M | 984.648 M | |
| Total Non-current Assets | 620.891 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 92.779 M | 65.987 M | 63.175 M | 60.970 M | 59.459 M | 57.189 M | 56.970 M | 55.371 M | |
| Other Assets | 24.545 M | 492.458 M | 497.511 M | 278.523 M | 279.522 M | 304.091 M | 578.927 M | 569.448 M | |
| Intangible Assets | 330.040 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 82.341 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.790 B | 1.916 B | 1.842 B | 1.705 B | 2.655 B | 2.634 B | 2.644 B | 2.899 B | |
| Total liabilities | 2.684 B | 2.897 B | 2.897 B | 2.803 B | 2.841 B | 2.841 B | 2.799 B | 3.104 B | |
| Total current liabilities | 574.546 M | 609.803 M | 610.712 M | 580.981 M | 595.391 M | 627.809 M | 866.245 M | 968.427 M | |
| Accounts Payable | 27.459 M | 338.800 M | 336.346 M | 304.292 M | 317.807 M | 338.945 M | 303.141 M | 381.272 M | |
| Other liabilities | 1.648 B | 1.946 B | 1.945 B | 1.937 B | 1.960 B | 1.927 B | 1.933 B | 2.136 B | |
| Current long term debt | 1.948 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 300.086 M | 284.806 M | 285.106 M | 285.412 M | 285.712 M | 286.013 M | 0.000 | 0.000 | |
| Other liabilities | 1.648 B | 1.946 B | 1.945 B | 1.937 B | 1.960 B | 1.927 B | 1.933 B | 2.136 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -893.916 M | -980.181 M | -1.054 B | -1.098 B | -185.760 M | -206.546 M | -155.758 M | -205.313 M | |
| Common stock | 76.496 M | 2.511 B | 2.531 B | 2.575 B | 2.609 B | 2.631 B | 2.668 B | 2.748 B | |
| Retained earnings | -3.375 B | -3.474 B | -3.581 B | -3.647 B | -2.780 B | -2.845 B | -2.829 B | -2.964 B |